argenx SE (EBR:ARGX)
619.20
+3.40 (0.55%)
Feb 21, 2025, 5:35 PM CET
argenx SE Revenue
argenx SE had revenue of $588.88M USD in the quarter ending September 30, 2024, with 73.28% growth. This brings the company's revenue in the last twelve months to $1.91B, up 85.56% year-over-year. In the year 2023, argenx SE had annual revenue of $1.27B with 187.66% growth.
Revenue (ttm)
$1.91B
Revenue Growth
+85.56%
P/S Ratio
21.53
Revenue / Employee
$1.66M
Employees
1,148
Market Cap
37.62B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.27B | 827.59M | 187.66% |
Dec 31, 2022 | 441.01M | -87.26M | -16.52% |
Dec 31, 2021 | 528.27M | 466.31M | 752.59% |
Dec 31, 2020 | 61.96M | -30.85M | -33.24% |
Dec 31, 2019 | 92.81M | 63.58M | 217.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 5.45B |
Fagron NV | 874.84M |
Ion Beam Applications | 465.75M |
Nyxoah | 5.08M |
Onward Medical | -188.00K |
Hyloris Pharmaceuticals | 6.94M |
Sequana Medical NV | 433.50K |
Biocartis Group NV | 60.82M |
argenx SE News
- 1 day ago - argenx SE (ARGX) Announces Upcoming Conference Call for 2024 Financial Results - GuruFocus
- 2 days ago - argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - GlobeNewsWire
- 2 days ago - Argenx Vaults 3,659% With Profit Growth Seen In Triple Digits; Earnings Next As Stock Hits Highs - Investor's Business Daily
- 4 weeks ago - argenx: Lofty Valuation Diminishes Appeal Amid Autoimmune Expansion (Rating Downgrade) - Seeking Alpha
- 5 weeks ago - Argenx cut to Sell at Deutsche Bank on valuation - Seeking Alpha
- 5 weeks ago - Immunology company argenx estimates higher product net sales from last year - Seeking Alpha
- 5 weeks ago - argenx SE (ARGX) Announces Preliminary 2024 Financial Results and Strategic Priorities for 2025 - GuruFocus
- 5 weeks ago - argenx Highlights 2025 Strategic Priorities - GlobeNewsWire